Predictive value of microsatellite instability for benefit from adjuvant fluorouracil chemotherapy in colorectal cancer

Comment

B Iacopetta et al. Gut. 2006 Nov.

. 2006 Nov;55(11):1671-2.

No abstract available

Conflict of interest statement

Conflict of interest: None declared.

Predictive value of microsatellite instability for benefit from adjuvant fluorouracil chemotherapy in colorectal cancer.
Jover R, Castells A, Llor X, Andreu M. Jover R, et al. Gut. 2006 Dec;55(12):1819-20. doi: 10.1136/gut.2006.105627. Gut. 2006. PMID: 17124161 Free PMC article. No abstract available.
Prospective evaluation of fluorouracil chemotherapy based on the genetic makeup of colorectal cancer.
Carethers JM. Carethers JM. Gut. 2006 Dec;55(12):1819. Gut. 2006. PMID: 17124162 Free PMC article. No abstract available.

Mismatch repair status in the prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer.
Jover R, Zapater P, Castells A, Llor X, Andreu M, Cubiella J, Piñol V, Xicola RM, Bujanda L, Reñé JM, Clofent J, Bessa X, Morillas JD, Nicolás-Pérez D, Payá A, Alenda C; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Jover R, et al. Gut. 2006 Jun;55(6):848-55. doi: 10.1136/gut.2005.073015. Epub 2005 Nov 18. Gut. 2006. PMID: 16299036 Free PMC article.

1. Benatti P, Gafa R, Barana D.et al Microsatellite instability and colorectal cancer prognosis. Clin Cancer Res 2005118332–8340. - PubMed
1. Ribic C M, Sargent D J, Moore M J.et al Tumor microsatellite‐instability status as a predictor of benefit from fluorouracil‐based adjuvant chemotherapy for colon cancer. N Engl J Med 2003349247–257. - PMC - PubMed
1. Carethers J M, Smith E J, Behling C A.et al Use of 5‐fluorouracil and survival in patients with microsatellite‐unstable colorectal cancer. Gastroenterology 2004126394–401. - PubMed
1. Lynch H T, Boland C R, Gong G.et al Phenotypic and genotypic heterogeneity in the Lynch syndrome: diagnostic, surveillance and management implications. Eur J Hum Genet 200614390–402. - PubMed
1. Ward R L, Turner J, Williams R.et al Routine testing for mismatch repair deficiency in sporadic colorectal cancer is justified. J Pathol 2005207377–384. - PubMed